Cargando…

Quantitative Receptor-Based Imaging of Tumor Proliferation with the Sigma-2 Ligand [(18)F]ISO-1

The sigma-2 receptor is expressed in higher density in proliferating (P) tumor cells versus quiescent (Q) tumor cells, thus providing an attractive target for imaging the proliferative status (i.e., P:Q ratio) of solid tumors. Here we evaluate the utility of the sigma-2 receptor ligand 2-(2-[(18)F]f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shoghi, Kooresh I., Xu, Jinbin, Su, Yi, He, June, Rowland, Douglas, Yan, Ying, Garbow, Joel R., Tu, Zhude, Jones, Lynne A., Higashikubo, Ryuji, Wheeler, Kenneth T., Lubet, Ronald A., Mach, Robert H., You, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779213/ https://www.ncbi.nlm.nih.gov/pubmed/24073202 http://dx.doi.org/10.1371/journal.pone.0074188

Ejemplares similares

The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine
por: Hornick, John R, et al.
Publicado: (2010)

4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies
por: Ikome, Hermia N., et al.
Publicado: (2016)

Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site
por: Xu, Jinbin, et al.
Publicado: (2011)

Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy
por: Kashiwagi, Hiroyuki, et al.
Publicado: (2007)

Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent
por: Bagchi, Devika P., et al.
Publicado: (2013)

Test–Retest Performance of a 1-Hour Multiparametric MR Image Acquisition Pipeline With Orthotopic Triple-Negative Breast Cancer Patient-Derived Tumor Xenografts
por: Ge, Xia, et al.
Publicado: (2019)

In Vivo Multi-Tissue Efficacy of Peroxisome Proliferator-Activated Receptor-γ Therapy on Glucose and Fatty Acid Metabolism in Obese Type 2 Diabetic Rats
por: Nemanich, Samuel, et al.
Publicado: (2013)

Sigma-2 ligands induce tumour cell death by multiple signalling pathways
por: Zeng, C, et al.
Publicado: (2012)

In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [(18)F]FDG and [(64)Cu]Cu-LLP2A PET
por: Ghai, Anchal, et al.
Publicado: (2021)

Radiation dosimetry of [(18)F]VAT in nonhuman primates
por: Karimi, Morvarid, et al.
Publicado: (2015)

47149 Imaging Tools for Early Detection of Kidney Disease.
por: Baldelomar, Edwin J., et al.
Publicado: (2021)

Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer
por: Garg, Gunjal, et al.
Publicado: (2014)

Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma
por: Kashiwagi, Hiroyuki, et al.
Publicado: (2009)

What is six sigma process management? /
por: Hayler, Rowland
Publicado: (2005)

TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death
por: Zeng, Chenbo, et al.
Publicado: (2019)

Sigma-2 receptors as a biomarker of proliferation in solid tumours
por: Wheeler, K T, et al.
Publicado: (2000)

Genomic and Metabolic Disposition of Non-Obese Type 2 Diabetic Rats to Increased Myocardial Fatty Acid Metabolism
por: Devanathan, Sriram, et al.
Publicado: (2013)

Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer
por: Zeng, C, et al.
Publicado: (2013)

Sigma-2 Receptor Ligand Binding Modulates Association between TSPO and TMEM97
por: Thejer, Bashar M., et al.
Publicado: (2023)

Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer
por: Hornick, John R, et al.
Publicado: (2012)

Sexual dimorphism in myocardial acylcarnitine and triglyceride metabolism
por: Devanathan, Sriram, et al.
Publicado: (2016)

Metal influence on the iso- and hetero-selectivity of complexes of bipyrrolidine derived salan ligands for the polymerisation of rac-lactide
por: Jones, Matthew D., et al.
Publicado: (2015)

Pharmacology and Therapeutic Potential of Sigma(1) Receptor Ligands
por: Cobos, E.J, et al.
Publicado: (2008)

Sigma-2 receptor ligands QSAR model dataset
por: Rescifina, Antonio, et al.
Publicado: (2017)

Defining the ligand-dependent proximatome of the sigma 1 receptor
por: Zhao, Jing, et al.
Publicado: (2023)

ISO 14000 - ISO 9000
por: Rothery, Brian

Galuminox: Preclinical validation of a novel PET tracer for non-invasive imaging of oxidative stress in vivo
por: Sivapackiam, Jothilingam, et al.
Publicado: (2020)

The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands
por: Gromek, Katarzyna A., et al.
Publicado: (2014)

Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity
por: Georgiadis, Markos-Orestis, et al.
Publicado: (2017)

Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
por: Vela, José Miguel
Publicado: (2020)

Effects of Sigma-1 Receptor Ligands on Peripheral Nerve Regeneration
por: Cottilli, Patrick, et al.
Publicado: (2022)

Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands
por: Dichiara, Maria, et al.
Publicado: (2023)

Correction to: Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer
por: Roy, Sudipta, et al.
Publicado: (2021)

Co-clinical FDG-PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Roy, Sudipta, et al.
Publicado: (2021)

Comparison of [(11)C]TZ1964B and [(18)F]MNI659 for PET imaging brain PDE10A in nonhuman primates
por: Liu, Hui, et al.
Publicado: (2016)

An Animal Model with a Cardiomyocyte-Specific Deletion of Estrogen Receptor Alpha: Functional, Metabolic, and Differential Network Analysis
por: Devanathan, Sriram, et al.
Publicado: (2014)

Optimal co-clinical radiomics: Sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging
por: Roy, Sudipta, et al.
Publicado: (2020)

Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands
por: Zampieri, Daniele, et al.
Publicado: (2023)

Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma
por: Longhitano, Lucia, et al.
Publicado: (2017)

Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors
por: Abbas, Haider, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m21to6ntg80ca7gmu9tfn707c9